U.S. Capital Wealth Advisors LLC Has $906,000 Position in Xylem Inc. (NYSE:XYL)

U.S. Capital Wealth Advisors LLC cut its stake in shares of Xylem Inc. (NYSE:XYL) by 5.2% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 7,918 shares of the industrial products company’s stock after selling 438 shares during the quarter. U.S. Capital Wealth Advisors LLC’s holdings in Xylem were worth $906,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. AtonRa Partners raised its position in shares of Xylem by 2.3% in the 4th quarter. AtonRa Partners now owns 4,001 shares of the industrial products company’s stock worth $458,000 after acquiring an additional 91 shares in the last quarter. FFT Wealth Management LLC raised its position in shares of Xylem by 4.1% in the 4th quarter. FFT Wealth Management LLC now owns 2,368 shares of the industrial products company’s stock worth $271,000 after acquiring an additional 93 shares in the last quarter. Patten Group Inc. raised its position in shares of Xylem by 0.3% in the 4th quarter. Patten Group Inc. now owns 31,112 shares of the industrial products company’s stock worth $3,558,000 after acquiring an additional 99 shares in the last quarter. Whittier Trust Co. of Nevada Inc. increased its position in Xylem by 4.6% in the 4th quarter. Whittier Trust Co. of Nevada Inc. now owns 2,238 shares of the industrial products company’s stock valued at $256,000 after buying an additional 99 shares in the last quarter. Finally, Boston Trust Walden Corp increased its position in Xylem by 3.2% in the 4th quarter. Boston Trust Walden Corp now owns 3,418 shares of the industrial products company’s stock valued at $391,000 after buying an additional 107 shares in the last quarter. 87.96% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of equities research analysts have commented on XYL shares. Royal Bank of Canada raised their price objective on Xylem from $157.00 to $162.00 and gave the company an “outperform” rating in a research note on Friday. Stifel Nicolaus upped their price objective on shares of Xylem from $136.00 to $150.00 and gave the stock a “buy” rating in a report on Wednesday, February 7th. Robert W. Baird raised their price objective on shares of Xylem from $151.00 to $155.00 and gave the company an “outperform” rating in a research note on Friday. BNP Paribas began coverage on shares of Xylem in a research report on Tuesday, March 12th. They set an “outperform” rating and a $150.00 target price for the company. Finally, Mizuho raised their price target on shares of Xylem from $110.00 to $135.00 and gave the company a “neutral” rating in a research report on Friday. Five investment analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. According to data from MarketBeat, Xylem presently has a consensus rating of “Moderate Buy” and a consensus target price of $140.70.

Insiders Place Their Bets

In other Xylem news, SVP Franz Cerwinka sold 2,408 shares of the company’s stock in a transaction dated Thursday, February 8th. The stock was sold at an average price of $121.79, for a total value of $293,270.32. Following the transaction, the senior vice president now directly owns 11,750 shares in the company, valued at approximately $1,431,032.50. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In other news, CAO Geri-Michelle Mcshane sold 1,000 shares of the company’s stock in a transaction dated Tuesday, February 20th. The stock was sold at an average price of $122.89, for a total value of $122,890.00. Following the completion of the transaction, the chief accounting officer now directly owns 2,935 shares in the company, valued at approximately $360,682.15. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Franz Cerwinka sold 2,408 shares of the company’s stock in a transaction dated Thursday, February 8th. The stock was sold at an average price of $121.79, for a total value of $293,270.32. Following the completion of the transaction, the senior vice president now owns 11,750 shares of the company’s stock, valued at $1,431,032.50. The disclosure for this sale can be found here. Corporate insiders own 0.27% of the company’s stock.

Xylem Price Performance

Shares of NYSE XYL opened at $138.27 on Monday. The company has a quick ratio of 1.22, a current ratio of 1.67 and a debt-to-equity ratio of 0.19. Xylem Inc. has a twelve month low of $87.59 and a twelve month high of $138.46. The company has a market capitalization of $33.52 billion, a PE ratio of 48.83, a PEG ratio of 2.67 and a beta of 1.08. The stock’s 50 day moving average price is $128.64 and its 200-day moving average price is $115.54.

Xylem (NYSE:XYL) last announced its earnings results on Thursday, May 2nd. The industrial products company reported $0.90 earnings per share for the quarter, topping analysts’ consensus estimates of $0.84 by $0.06. The business had revenue of $2.03 billion for the quarter, compared to analyst estimates of $2 billion. Xylem had a return on equity of 8.95% and a net margin of 8.34%. The company’s quarterly revenue was up 40.4% compared to the same quarter last year. During the same period in the prior year, the company earned $0.72 EPS. On average, equities analysts anticipate that Xylem Inc. will post 4.24 EPS for the current year.

Xylem Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, March 20th. Shareholders of record on Wednesday, February 21st were paid a $0.36 dividend. This is a positive change from Xylem’s previous quarterly dividend of $0.33. This represents a $1.44 dividend on an annualized basis and a yield of 1.04%. The ex-dividend date was Tuesday, February 20th. Xylem’s dividend payout ratio is currently 51.25%.

Xylem Profile

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.